I’m not negative, just objective . im not taking a dig at you, but can you seriously interpret clinical data? Let me give you an example hopefully you understand… imagine an absolutely boring book with crap pictures in them right? Now the author keeps saying how awesome and excited they are with the book, but surely you can open the book and see for yourself the contradiction? we have a great UMSARS score but not statistical significance for other end points. now I ask you, if they are discussing with partners and if YOU were say Pfizer , would you want to partner on such data? Be objective in life. Zero emotions. frankly I still feel they will Goto the FDA with a strong case to try and get AA but they will need to plan a phase 3 and the phase 3 will have to be a bulletproof design to capture more endpoints. Which probably means a few months wait till the study design is determined and they probably won’t end up going to FDA till probably August. these are my opinions only. DYOR
ATH Price at posting:
0.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)